新鲜冷冻半月板同种异体移植软组织固定的长期结局与移植物生存率:至少10年随访研究
该病例系列研究纳入46例接受关节镜下新鲜冷冻半月板同种异体移植(MAT)软组织固定的患者,至少随访10年。10年无手术失败生存率为86%,无手术及临床失败生存率为70%,最终随访Lysholm评分为82±20,60%至82%的患者达到KOOS各亚量表的可接受症状状态(PASS)。侧方MAT失败风险高于内侧MAT(73% vs 96%),女性患者再手术次数更多。
要点
- 10年无手术失败生存率为86%,无手术及临床失败生存率为70%。
- 侧方MAT生存率73%低于内侧MAT的96%。
- 最终随访Lysholm评分82±20,60%至82%患者达到KOOS各亚量表PASS。
核心结论
- 术后长达10年,86%的新鲜冷冻MAT软组织固定移植物仍在位,约70%的患者获得满意的临床结果。
- 仅运动相关评分从中期到长期评估出现下降。
- 女性患者总体再手术次数更多,侧方MAT患者失败风险更高。
研究设计与样本
- 病例系列研究,证据等级4级。
- 共46例患者(年龄36.6±10.6岁;男36例,女10例)接受内侧MAT(n=27)或外侧MAT(n=19),至少随访10年。
- 采用Lysholm评分、KOOS、疼痛视觉模拟评分和Tegner评分评估。
- 手术失败定义为需要部分或全部移植物移除(半月板切除或膝关节置换),临床失败定义为需要部分或全部移植物移除加上最终随访Lysholm评分差(<65分)。
- 采用Kaplan-Meier曲线进行生存分析,临床评分基于MAT的PASS进行分析。
主要发现
- 38例患者获得10年生存和临床数据。
- 因需6例半月板切除,无手术失败生存率5年为91%,10年为86%。
- 侧方MAT生存率73%低于内侧MAT的96%。
- 另有4例患者Lysholm评分差,无手术及临床失败生存率5年为87%,10年为70%。
- 最终随访平均Lysholm评分为82±20,60%至82%的患者达到KOOS各亚量表的PASS。
关键数值与推荐
- 手术失败定义为需要部分或全部移植物移除(半月板切除或膝关节置换)。
- 临床失败定义为需要部分或全部移植物移除加上最终随访Lysholm评分<65分。
- 无手术失败生存率:5年91%,10年86%。
- 无手术及临床失败生存率:5年87%,10年70%。
- 侧方MAT生存率73% vs 内侧MAT 96%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meniscal allograft transplant (MAT) is considered an effective procedure for reducing pain and improving knee function. Nevertheless, the current knowledge regarding the results of MAT is limited to short- to mid-term follow-up studies, especially for arthroscopic techniques. PURPOSE: To evaluate the long-term clinical outcomes, reoperations, and failures with a minimum follow-up of 10 years after fresh-frozen MAT performed arthroscopically with soft tissue fixation. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A total of 46 patients (age, 36.6 ± 10.6 years; 36 male, 10 female) who underwent medial MAT (n = 27) or lateral MAT (n = 19) with a minimum 10-year follow-up were evaluated with the Lysholm score, Knee injury and Osteoarthritis Outcome Score (KOOS), visual analog scale for pain, and Tegner score. Surgical failure was defined as the need for partial or total graft removal (meniscectomy or knee replacement), and clinical failure was defined as the need for partial or total graft removal in addition to a poor Lysholm score (<65 points) at final follow-up. Survival analysis was performed with Kaplan-Meier curve, and clinical scores were analyzed based on the Patient Acceptable Symptom State (PASS) for MAT. RESULTS: 10-year survival and clinical data were available for 38 patients. Because 6 meniscectomies were required, the rate of survival free from surgical failure was 91% at 5 years and 86% at 10 years. Lower survival was reported in lateral MAT (73%) compared with medial MAT (96%). Because a further 4 patients had poor Lysholm scores, the rate of survival free from surgical and clinical failure was 87% at 5 years and 70% at 10 years. The average Lysholm score at final follow-up was 82 ± 20, and 60% to 82% of patients achieved PASS of the various KOOS subscales. The Tegner score and the KOOS Sport score significantly decreased from mid-term to long-term evaluation (P < .001 and P < .05, respectively). Other KOOS subscales and the Lysholm score remained stable at long-term evaluation. No significant differences were found between isolated MAT or combined MAT regarding subjective scores, surgical failures, or clinical failures. CONCLUSION: Up to 10 years after surgery, 86% of fresh-frozen MATs with soft tissue fixation were still in situ, and satisfactory clinical results were present for about 70% of patients. Decline of clinical outcomes from midterm to long term was noted only in sports-related scores. A higher number of overall reoperations was noted in female patients, whereas a higher risk of failure was present in the patients with lateral MAT.
引用
- Grassi A, Macchiarola L, Lucidi GA, et al. Long-term Outcomes and Survivorship of Fresh-Frozen Meniscal Allograft Transplant With Soft Tissue Fixation: Minimum 10-Year Follow-up Study. Am J Sports Med. 2020. PMID: 32628513. doi:10.1177/0363546520932923
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。